Sign inGet started

Trachtenberg Eric

Insider CIK 1646300 · POZN Deputy General Counsel · KALA See Remarks · ARLZ General Counsel, COO & Sect

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
KALA KALA BIO, Inc. A Award deriv2024-01-042024-01-0520,500— $020,500SEC↗
KALA KALA BIO, Inc. A Award2024-01-042024-01-054,600— $069,293SEC↗
KALA KALA BIO, Inc. S Sale2024-01-042024-01-051,227$6.74 $8.3K68,066SEC↗
KALA Kala Pharmaceuticals, Inc. A Award deriv2023-06-222023-06-2350,078— $050,078SEC↗
KALA Kala Pharmaceuticals, Inc. A Award2023-06-222023-06-2337,559— $064,693SEC↗
KALA Kala Pharmaceuticals, Inc. D To issuer deriv2023-05-312023-06-02648— $00SEC↗
KALA Kala Pharmaceuticals, Inc. D To issuer deriv2023-05-312023-06-023,059— $00SEC↗
KALA Kala Pharmaceuticals, Inc. D To issuer deriv2023-05-312023-06-021,813— $00SEC↗
KALA Kala Pharmaceuticals, Inc. D To issuer deriv2023-05-312023-06-022,399— $00SEC↗
KALA Kala Pharmaceuticals, Inc. D To issuer deriv2023-05-312023-06-022,721— $00SEC↗
KALA Kala Pharmaceuticals, Inc. D To issuer deriv2023-05-312023-06-023,000— $00SEC↗
KALA Kala Pharmaceuticals, Inc. D To issuer deriv2023-05-312023-06-021,999— $00SEC↗
KALA Kala Pharmaceuticals, Inc. A Award2023-05-312023-06-0215,639— $027,134SEC↗
KALA Kala Pharmaceuticals, Inc. A Award deriv2023-03-142023-03-15432— $0432SEC↗
KALA Kala Pharmaceuticals, Inc. S Sale2023-01-042023-01-0660$28.55 $1.7K11,495SEC↗
KALA Kala Pharmaceuticals, Inc. A Award2023-01-042023-01-069,525— $011,555SEC↗
KALA Kala Pharmaceuticals, Inc. S Sale2022-10-262022-10-28194$6.52 $1.3K2,030SEC↗
KALA Kala Pharmaceuticals, Inc. S Sale2022-06-272022-06-292,613$0.37 $967111,203SEC↗
KALA Kala Pharmaceuticals, Inc. S Sale2022-01-042022-01-052,850$1.30 $3.7K113,816SEC↗
KALA Kala Pharmaceuticals, Inc. A Award deriv2022-01-032022-01-05153,000— $0153,000SEC↗
KALA Kala Pharmaceuticals, Inc. S Sale2021-10-262021-10-289,449$1.80 $17.0K116,666SEC↗
KALA Kala Pharmaceuticals, Inc. S Sale2021-06-282021-06-292,452$5.77 $14.1K126,115SEC↗
KALA Kala Pharmaceuticals, Inc. A Award deriv2021-01-042021-01-0590,667— $090,667SEC↗
KALA Kala Pharmaceuticals, Inc. A Award2021-01-042021-01-0522,666— $0128,567SEC↗
KALA Kala Pharmaceuticals, Inc. A Award2020-10-262020-10-2861,000— $0105,901SEC↗
KALA Kala Pharmaceuticals, Inc. A Award2020-06-252020-06-2916,000— $044,901SEC↗
KALA Kala Pharmaceuticals, Inc. M Exercise deriv2020-06-192020-06-2228,901— $0136,099SEC↗
KALA Kala Pharmaceuticals, Inc. M Exercise2020-06-192020-06-2228,901$5.19 $150.0K28,901SEC↗
KALA Kala Pharmaceuticals, Inc. A Award deriv2020-01-022020-01-03120,000— $0120,000SEC↗
KALA Kala Pharmaceuticals, Inc. A Award deriv2019-10-122019-10-15100,000— $0100,000SEC↗
KALA Kala Pharmaceuticals, Inc. A Award deriv2019-01-022019-01-04165,000— $0165,000SEC↗
KALA Kala Pharmaceuticals, Inc. A Award deriv2018-04-052018-04-09150,000— $0150,000SEC↗
ARLZ Aralez Pharmaceuticals Inc S Sale2018-03-192018-03-213,471$1.70 $5.9K198,093SEC↗
ARLZ Aralez Pharmaceuticals Inc S Sale2017-06-232017-06-237,720$1.33 $10.3K201,564SEC↗
ARLZ Aralez Pharmaceuticals Inc A Award deriv2017-05-112017-05-1274,851— $074,851SEC↗
ARLZ Aralez Pharmaceuticals Inc A Award2017-05-112017-05-1264,784— $0209,284SEC↗
ARLZ Aralez Pharmaceuticals Inc P Buy2016-05-162016-05-1810,000$3.76 $37.6K144,500SEC↗
ARLZ Aralez Pharmaceuticals Inc A Award deriv2016-03-172016-03-1829,203— $029,203SEC↗
ARLZ Aralez Pharmaceuticals Inc A Award2016-03-172016-03-1834,500— $0134,500SEC↗
ARLZ Aralez Pharmaceuticals Inc A Award2016-02-122016-02-1775,000— $0100,000SEC↗
ARLZ Aralez Pharmaceuticals Inc J Other2016-02-052016-02-0925,000— $025,000SEC↗
POZN POZEN INC /NC A Award2015-06-222015-06-2525,000— $025,000SEC↗